TCON - TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q2 2021 Results - Earnings Call Transcript
TRACON Pharmaceuticals (TCON) Q2 2021 Results Earnings Conference Call August 12, 2021, 08:00 AM ET Company Participants Charles Theuer - President and Chief Executive Officer Scott Brown - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Joanne Lee - Maxim Group Edward White - H.C. Wainwright & Co. Matthew Cross - Alliance Global Partners Nick Abbott - Wells Fargo Soumit Roy - Jones Trading Presentation Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Second Quarter 2021 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers' prepared remarks, we will conduct a question-and-answer session and instructions will be given at that time. During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and/or development plans and strategy. These statements are subject to
For further details see:
TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q2 2021 Results - Earnings Call Transcript